Examination of pituitary gland function

Physiology and pathophysiology of the pituitary gland
thumb|220px|right|Pituitary portal circulation
 * The pituitary gland is an endocrine gland located on the cranial base and formed by two lobes with different ontogenesis, structure, function and regulation - anterior lobe (adenohypophysis) and posterior lobe (neurohypophysis).
 * Pituitary is a stem associated with Hypothalamus, which regulates pituitary function through hypothalamic hormones released into the capillary branches of the hypothalamic-pituitary portal system.
 * Pituitary hormones have direct metabolic, cardiovascular and other effects on target tissues, but above all, through them the pituitary gland controls the function of peripheral endocrine glands - adrenal cortex, thyroid gland and gonads.

Adenohypophysis

 * Anterior pituitary lobe (adenohypophysis) makes up 80% of the pituitary's weight.
 * It is made up of glandular cells that synthesize and release into the circulation hormones of the protein structure - adrenocorticotropic hormone (ACTH), thyrotropic hormone (TSH), prolactin, somatotropic hormone (STH, growth hormone), endorphins, follicle stimulating hormone (FSH) and  luteotropic hormone  (LH).
 * The secretion of these hormones is regulated (stimulated or inhibited) by hypothalamic hormones (releasing and inhibiting factors).
 * Adenohypophysis arises during ontogenesis from Rathke's protrusion of the posterior wall of the pharynx.

Neurohypophysis

 * The posterior lobe of the pituitary gland (neurohypophysis) is a functional and embryonic outbreak of the hypothalamus.
 * It consists mainly of axonal endings of neurons in the supraoptic and paraventricular nuclei of the hypothalamus. These axons release the peptide hormones oxytocin and antidiuretic hormone.
 * The posterior lobe also contains pituicytes, specialized glial cells related to astrocytes.

Indications for examination
Endocrinological examination of the pituitary gland is indicated in case of clinical suspicion of:
 * 1) functional disorder,
 * 2) hypofunction = hypopituitarism, can be isolated, ie affecting one hormone, partial to complete, ie  panhypopituitarism ,
 * 3) hyperfunction (in most cases it is an overproduction of one hormone) - Cushing's syndrome, gigantism, [ [acromegaly]] , prolactin ,
 * 4) expansionary process in the area of ​​the Turkish saddle (which is also often accompanied by a functional disorder),
 * 5) pituitary adenoma,
 * 6) craniopharyngeal, chordoma, meningioma, glioma or other type of tumor.


 * Pituitary Adenoma can be hormonally  dysfunctional , or  hyperfunctional . The tumor itself can induce either isolated or complete hypopituitarism, possibly by pressure on the surrounding tissue or by disrupting the hypothalamic-pituitary junction. diabetes insipidus.
 * An example of a hormonally "functional" pituitary tumor is the so-called "pseudoprolactin", which disrupts the transport of "dopamine" (prolactin-inhibiting hormone) into the pituitary by breaking the connection between the hypothalamus and the pituitary, with a consequent increase in prolactin secretion.
 * Complications of pituitary tumors also include local invasion (damage to the visual tract, hypothalamic syndromes), hemorrhage, infarction, infection or malignant transformation
 * Autoimmune inflammation = pituitary - may also manifest as (pseudotumorous) pituitary expansion accompanied by a hormonal disorder (usually partial hypopituitarism). Swapping pituitary with adenoma can lead to incorrectly indicated surgery.

Examination procedure
The investigation procedure includes
 * 1) pituitary imaging methods (MRI or CT)
 * 2) hormonal examination - basal hormonal concentrations determined once or repeatedly during the day. functional (stimulation and inhibition) tests,
 * 3) biochemical and other laboratory tests in relation to presumed endocrinopathy (glycaemia, sodium, potassium, blood count, etc.),
 * 4) ophthalmological examination (especially visual field examination), event. neurological examination and others.

Imaging Methods
 'Magnetic Resonance Imaging (MRI)' 
 * Basic imaging method for suspected pituitary disease.

 Comparison of MRI and CT in relation to pituitary examination 

Hormonal examination

 * 1) exclude in the first place prolactinoma - unlike other hyperfunctional syndromes, there is primary medical treatment and not surgical treatment;
 * 2) rule out overproduction of other hormones - STH (acromegaly), ACTH (Cushing's disease), TSH (central hyperthyroidism); gonadotropins;
 * 3) diagnose hormonal deficits (hypopituitarism);
 * 4) exclude (anamnestic, possibly followed by a concentration test) diabetes insipidus.

Prolactinoma

 * Clinical pictur:
 * serum PRL concentrations - repeated intakes,
 * response to dopaminergic agonists (therapeutic test) - in most cases the PRL level will decrease within a few weeks and later the tumor will regress,
 * In differential diagnosis it is necessary to distinguish (true) prolactinoma from pseudoprolactinoma.

Acromegaly

 * Clinical picture:
 * serum STH concentrations basally - 3 samples at hourly intervals (due to circadian rhythm),
 * serum IGF-I levels (single test),
 * glucose inhibition test with determination of STH concentration.

Glucose Inhibition Test
 * Test principle: hyperglycemia suppresses STH and ACTH secretion. After administration of 100 g of glucose orally on an empty stomach, the STH concentration drops below 1 μmol/l under physiological conditions.

Cushing's syndrome

 * Clinical picture:
 * free urinary cortisol - 24 hour collection,
 * plasma cortisol - repeated intakes taking into account the circadian rhythm (or at least morning intake and intake at 11 pm),
 * plasma ACTH,
 * dexamethasone suppression test (usually a short test with a low dose of dexamethasone).

Dexamethasone suppression test
Stimulation test with corticotropin releasing factor (CRF, 100 µg) with inferior sine petrosus catheterization
 * The inferior petrosus sinus (SPI) is a venous raft that drains blood from the adenohypophysis. Local ACTH blood levels taken bilaterally from SPI (before and after CRF stimulation) are compared to peripheral blood ACTH levels.
 * Use of the test in the differential diagnosis of Cusing syndrome, between the pituitary microadenoma and paraneoplastic Cushing's syndrome, if the diagnosis was not possible by less demanding methods. In the case of paraneoplastic ACTH production (tumor production of ACTH outside the pituitary gland), there is no corresponding increase in ACTH levels in SPI after corticoliberin stimulation, because negative feedback predominates (peripheral tumor ACTH inhibits pituitary ACTH secretion).

Central hyperthyroidism

 * Clinical picture:
 * serum concentrations of TSH, free T4 and free T3.

Overproduction of gonadotropins

 * Compared to previous hyperfunctional syndromes, it is much rarer.
 * Clinical picture is not specific for diagnosis.
 * LH, FSH, + men: testosterone.

Hypopituitarimus

 * Demonstration of partial or complete disorders of adenohypophyseal hormones, event. in combination with diabetes insipidus.
 * hypocorticalism (plasma cortisol),
 * central hypothyroidism (TSH, free T4),
 * hypogonadism (LH, FSH, testosterone in men, menses in women),
 * STH deficiency (STH in insulin stimulation test, IGF-I).

Insulin Hypoglycemic Test
 * Test principle: Insulin-induced hypoglycemia stimulates the secretion of counterregulatory hormones, including ACTH, STH. Deficiency of ACTH and STH synthesis is manifested in the test by insufficient increase of their serum concentrations.

'Methyrapone test  '
 * Test principle: Metyrapone is a synthetic blocker of adrenal steroidogenesis. Blockade of cortisol synthesis by metyrapone stimulates ACTH secretion in the pituitary via feedback. ACTH synthesis deficiency is manifested by an insufficient increase within 120 minutes after metyrapone administration.

Stimulus tests using hypothalamic releasing factors It is often performed as a combined stimulation test with the simultaneous administration of several of the following factors, possibly in combination with an insulin test:
 * Principle of tests: Intravenous single application of releasing factors selectively stimulates the secretion of pituitary hormones.
 * thyrotropin releasing hormon (TRH, 200 µg),
 * gonadotropin releasing hormone (GnRH, 100 µg),
 * growth hormone releasing hormon (GRF1-44, 100 µg).

Visual field examination (perimeter)

 * Symptoms of oppression of the opticus nervous process by expansive process: scotomas, defects of the upper temporal quadrants, bitemporal hemianopia (bilateral failure of the lateral parts of the visual field), to blindness.

Related articles

 * Hypophysis
 * Examination of pituitary gland function
 * Endocrine diseases of the gonads

Literature
Portal:Pathophysiology Portal:Internal medicine Portal:Endocrinology